UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

JAMA : the journal of the American Medical Association, 2006-01, Vol.295 (3), p.293

2006

Link zum Volltext

Verfügbarkeit prüfen

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Nature reviews. Drug discovery, 2010-07, Vol.9 (7), p.519-522

2010

Link zum Volltext

Verfügbarkeit prüfen

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

Annals of internal medicine, 2003-05, Vol.138 (10), p.807

2003

Link zum Volltext

Verfügbarkeit prüfen

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007

Pediatrics (Evanston), 2008-06, Vol.121 (6), p.1206

2008

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

American journal of preventive medicine, 2010-10, Vol.39 (4), p.296-304

2010

Link zum Volltext

Verfügbarkeit prüfen

Kawasaki Disease After Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990–2007

The Pediatric infectious disease journal, 2009-11, Vol.28 (11), p.943-947

2009

Link zum Volltext

Verfügbarkeit prüfen

Answering Key Questions About COVID-19 Vaccines

JAMA : the journal of the American Medical Association, 2020-11, Vol.324 (20), p.2027

2020

Link zum Volltext

Verfügbarkeit prüfen

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005

Vaccine, 2007-05, Vol.25 (21), p.4244-4251

2007

Link zum Volltext

Verfügbarkeit prüfen

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents

Journal of rheumatology, 2004-10, Vol.31 (10), p.1955

2004

Link zum Volltext

Verfügbarkeit prüfen

Toward better vaccine safety data and safer vaccination

Pediatrics (Evanston), 2008-03, Vol.121 (3), p.625

Braun, M Miles

2008

Link zum Volltext

Verfügbarkeit prüfen

Orphan products: an emerging trend in drug approvals

Nature reviews. Drug discovery, 2010-01, Vol.9 (1), p.84-84

2010

Link zum Volltext

Verfügbarkeit prüfen

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

JAMA : the journal of the American Medical Association, 2009-08, Vol.302 (7), p.750

2009

Link zum Volltext

Verfügbarkeit prüfen

Infectious complications of biologic treatments of rheumatoid arthritis

Current opinion in rheumatology, 2003-05, Vol.15 (3), p.179-184

2003

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent

The New England journal of medicine, 2001-10, Vol.345 (15), p.1098

2001

Link zum Volltext

Verfügbarkeit prüfen

Adverse event reports following yellow fever vaccination

Vaccine, 2008-11, Vol.26 (48), p.6077-6082

2008

Link zum Volltext

Verfügbarkeit prüfen

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

Journal of the American Academy of Dermatology, 2005-09, Vol.53 (3), p.407-415

2005

Link zum Volltext

Verfügbarkeit prüfen

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

The Pediatric infectious disease journal, 2004-04, Vol.23 (4), p.287-294

2004

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor

Clinical infectious diseases, 2004-08, Vol.39 (3), p.295-299

2004

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

Journal of allergy and clinical immunology, 2004-03, Vol.113 (3), p.536-542

2004

Link zum Volltext

Verfügbarkeit prüfen

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Journal of bone and joint surgery. American volume, 2006-03, Vol.88 (3), p.503

2006

Link zum Volltext

Verfügbarkeit prüfen

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

JAMA : the journal of the American Medical Association, 2005-12, Vol.294 (21), p.2720

2005

Link zum Volltext

Verfügbarkeit prüfen

Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

Vaccine, 2007-02, Vol.25 (10), p.1727-1734

2007

Link zum Volltext

Verfügbarkeit prüfen

What Should an Ideal Vaccine Postlicensure Safety System Be?

American journal of public health (1971), 2009-10, Vol.99 (S2), p.S345-S350

2009

Link zum Volltext

Verfügbarkeit prüfen

Varicella–Zoster Vaccine

The New England journal of medicine, 2007-07, Vol.357 (1), p.88-90

2007

Link zum Volltext

Verfügbarkeit prüfen

STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AFTER VACCINATION: REPORTS TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM

The Pediatric infectious disease journal, 2001-02, Vol.20 (2), p.219-223

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(127)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Humans
(106)
Science & Technology
(103)
Life Sciences & Biomedicine
(100)
Male
(61)
Biological And Medical Sciences
(54)
Female
(54)
Medical Sciences
(50)
Adult
(40)
United States
(37)
Middle Aged
(36)
Adverse Drug Reaction Reporting Systems
(31)
Infant
(31)
Aged
(30)
Infectious Diseases
(30)
Adolescent
(27)
Immunology
(25)
Child
(24)
Child, Preschool
(24)
General & Internal Medicine
(23)
Medicine, General & Internal
(23)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years

Case reports of heart failure after therapy with a tumor necrosis factor antagonist

Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007

Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001

Kawasaki Disease After Vaccination: Reports to the Vaccine Adverse Event Reporting System 1990–2007

Answering Key Questions About COVID-19 Vaccines

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005

Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents

Toward better vaccine safety data and safer vaccination

Orphan products: an emerging trend in drug approvals

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

Infectious complications of biologic treatments of rheumatoid arthritis

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent

Adverse event reports following yellow fever vaccination

Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System

Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases

What Should an Ideal Vaccine Postlicensure Safety System Be?

Varicella–Zoster Vaccine

STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS AFTER VACCINATION: REPORTS TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM

Suchergebnisse filtern